Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Abramowicz

Showing results (61-70 of 137) with videos related to

Pageof 14
Sort By:
Transplantation|March 7, 2008
HLA mismatches remain risk factors for acute kidney allograft rejection in patients receiving quadruple immunosuppression with anti-interleukin-2 receptor antibodiesKarl M Wissing, Guy Fomegné, Nilufer Broeders, et al.
Clinical Nephrology|October 18, 2013
Does basiliximab induction trigger lifethreatening ARDS and shock in young patients after kidney transplantation?Annick Massart, Sarah Heenen, Gilbert Bejjani, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 10, 2009
Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) hepatitis C guidelines: a European Renal Best Practice (ERBP) position statementAdrian Covic, Daniel Abramowicz, Annette Bruchfeld, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 17, 2018
Prospective randomized study of conversion from tacrolimus to cyclosporine A to improve glucose metabolism in patients with posttransplant diabetes mellitus after renal transplantationKarl M Wissing, Daniel Abramowicz, Laurent Weekers, et al.
Clinical Kidney Journal|March 18, 2016
Therapeutic drug monitoring of enteric-coated mycophenolate sodium by limited sampling strategies is associated with a high rate of failureJean-Michel Hougardy, Laurette Maufort, Frédéric Cotton, et al.
Transplant Immunology|June 17, 2018
The clinical significance of epitope mismatch load in kidney transplantation: A multicentre studyLiesbeth Daniëls, Maarten Naesens, Jean-Louis Bosmans, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 30, 2021
Waiting Time for Second Kidney Transplantation and MortalityAlexander Kainz, Michael Kammer, Roman Reindl-Schwaighofer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 8, 2014
Strategies to increase the donor pool and access to kidney transplantation: an international perspectiveUmberto Maggiore, Rainer Oberbauer, Julio Pascual, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 11, 2017
Long-term risks of kidney living donation: review and position paper by the ERA-EDTA DESCARTES working groupUmberto Maggiore, Klemens Budde, Uwe Heemann, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 23, 2020
How should I manage immunosuppression in a kidney transplant patient with COVID-19? An ERA-EDTA DESCARTES expert opinionUmberto Maggiore, Daniel Abramowicz, Marta Crespo, et al.
Pageof 14

Showing results (61-70 of 137) with videos related to

Sort By:
Pageof 14
Transplantation|March 7, 2008
HLA mismatches remain risk factors for acute kidney allograft rejection in patients receiving quadruple immunosuppression with anti-interleukin-2 receptor antibodiesKarl M Wissing, Guy Fomegné, Nilufer Broeders, et al.
Clinical Nephrology|October 18, 2013
Does basiliximab induction trigger lifethreatening ARDS and shock in young patients after kidney transplantation?Annick Massart, Sarah Heenen, Gilbert Bejjani, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 10, 2009
Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) hepatitis C guidelines: a European Renal Best Practice (ERBP) position statementAdrian Covic, Daniel Abramowicz, Annette Bruchfeld, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 17, 2018
Prospective randomized study of conversion from tacrolimus to cyclosporine A to improve glucose metabolism in patients with posttransplant diabetes mellitus after renal transplantationKarl M Wissing, Daniel Abramowicz, Laurent Weekers, et al.
Clinical Kidney Journal|March 18, 2016
Therapeutic drug monitoring of enteric-coated mycophenolate sodium by limited sampling strategies is associated with a high rate of failureJean-Michel Hougardy, Laurette Maufort, Frédéric Cotton, et al.
Transplant Immunology|June 17, 2018
The clinical significance of epitope mismatch load in kidney transplantation: A multicentre studyLiesbeth Daniëls, Maarten Naesens, Jean-Louis Bosmans, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 30, 2021
Waiting Time for Second Kidney Transplantation and MortalityAlexander Kainz, Michael Kammer, Roman Reindl-Schwaighofer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 8, 2014
Strategies to increase the donor pool and access to kidney transplantation: an international perspectiveUmberto Maggiore, Rainer Oberbauer, Julio Pascual, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 11, 2017
Long-term risks of kidney living donation: review and position paper by the ERA-EDTA DESCARTES working groupUmberto Maggiore, Klemens Budde, Uwe Heemann, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 23, 2020
How should I manage immunosuppression in a kidney transplant patient with COVID-19? An ERA-EDTA DESCARTES expert opinionUmberto Maggiore, Daniel Abramowicz, Marta Crespo, et al.
Pageof 14